Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001140361-17-036614

Director sold 5,000 shares at $17.30 ($86,476)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GLUCK FREDERICK W Director 2017-09-26 Sale −5,000 $17.30 $86,476 321,643 I
Open-market sales · 5,000 sh · avg $17.30 · $86,476
Loading xslF345X03/doc1.xml…